EMToxCast: Recent Episodes

rjhamiltonmd

Professor and Chair of Emergency Medicine EM Physician and Toxicologist ... with a little Aerospace Medicine for fun

View Details

First PodCast from my new home - Crozer Keystone Health System! Featuring Mark Saks the EM Program Director and a longtime friend and colleague.

View Details

April Journal Club Drexel EM

View Details

Drexel EM Journal Club March 2019 by rjhamiltonmd

View Details

Pod cast after our first ever Decision Science Rounds!

View Details

November Journal Club for the Drexel Emergency Medicine Residenct

View Details

Journal club discussing epinephrine in cardiac arrest, which medications for sedation of the agitated patient, and putting to bed the controversy on fluid resuscitation in pediatric DKA

View Details

Blue Zones in Medicine: The Role of Social Media - can social media save medicine? by rjhamiltonmd

View Details

Why do patients come to the ED? For the SALT-ED Sugar Alcohol of course!! Find out more by listening in ...

View Details

Journal Club February 2018 by rjhamiltonmd

View Details

Heart Failure by rjhamiltonmd

View Details

Dr David Vearrier, Program Director of the Medical Toxicology Fellowship here at Drexel University College of Medicine, joins me to discuss opioid withdrawal pathophysiology and treatment. We talk about our developing suboxone program and other approaches to treatment.

View Details

Peeling The Banana Out Of The Bag by rjhamiltonmd

View Details

I am joined by Rick McKnight PhD and Curt Woolford MA, E-RYT as we review a recent workshop/retreat we did on building resilience in emergency medicine, mindfulness, and a recent article on beating stress in high performance situations. Then we went out for Japanese BBQ and finished the evening with 'smores - now that's resilience building!

View Details

Dr. Rita McKeever, toxicologist extraordinaire, discusses the use of an early APAP level in patients with low probability of APAP overdose.

View Details

Heroin overdoses and naloxone reversal: ok for discharge or mandatory observation? by rjhamiltonmd

View Details

Grand Rounds at Morristown Department of Emergency Medicine July 2016

View Details

Dr. Dan Mirsch Drexel EM2 joins me for the next episode in our continuing series on the cardinal presentations in emergency medicine - chest pain.

View Details

Continuing series on cardinal signs tackles a common complaint - dyspnea. Part 2

View Details

Continuing series on cardinal signs tackles a common complaint - dyspnea

View Details

A review of the approach to headache in the Emergency Department for medical students

View Details

First in a series of PodCasts for Med Students and Interns on cardinal presentations in EM

View Details

Journal Club articles Podcast! Abscesses: Lancing the myths

View Details

If you are a med student getting ready for the start of fourth year and EM Clerkships and Sub Internships - this podcast is for you!

View Details

Some insights into the phenomenon of K2 Krash - hypotension and bradycardia after synthetic cannabinoid overdose.

View Details

In this podcast I review "Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess" Talan et al NEJM 2016;374:823-32 and see what the clinical advantage to adding TM-SMX to simple I&D. Then we take a quick turn to some Tox and look at "Extracorporeal membrane oxygenation in the treatment of poisoned patients" deLange et al in Clinical Toxicology 2013;51:385-393.

View Details

In this interview I am excited to introduce Ernie as the new Program Director for our incoming class of interns. I talk with Ernie about his new position, what motivates him to teach, and we have deep thoughts on autonomy, mastery, and purpose. Shout out to all our fantastic EM Program Candidates and I hope you enjoy the podcast. Get in touch for any questions you might have for Ernie (or anyone) and good luck in the Match! See you in June!

View Details

Journal Club PodCast: Flipped classroom! Assignment is to read the articles, listen to the podcast, and be prepared to apply your knowledge to clinical scenarios when you come to Journal Club.

Articles are: Acute stroke intervention: A systematic review JAMA April 14, 2015 Endovascular Therapy after IV TPA versus TPA alone for stroke NEJM March 7 2013 Comparative efficacy of different acute reperfusion therapies for acute ischemic stroke: a comprehensive benefit-risk analysis of clinical trials Brain and Behavior 2014 A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: lessons for tools developers BMC Health Services Research 2013

Opinions are of course are own...!

Music is "Heartbeats" by Cat Hamilton created exclusively for this podcast - how cool is that!

View Details

Neurocritical Care Society and Society for Critical Care Medicine recommendations for reversal of antithrombotic agents in patients with intracranial hemorrhage Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage : A Statement for Healthcare Professionals from the Neurocritical Care Society... - PubMed - NCBI http://www.ncbi.nlm.nih.gov/pubmed/26714677 Antithrombotic: Timing, Antidote, Factor Replacement, antifibrinolytics Vitamin K antagonists (warfarin) If INR > 1.3 then Vitamin K 10 mg IV, plus 3 or 4 factor PCC IV (dosing based on weight, INR and PCC type) OR FFP 10–15 ml/kg IV if PCC not available Direct factor Xa inhibitors: activated charcoal (50 g) within 2 h of ingestion, activated PCC (FEIBA) 50 units/kg IV OR 4 factor PCC 50 units/kg IV Direct thrombin inhibitors (dabigatran): Activated charcoal (50 g) within 2 h of ingestion, AND Activated PCC (FEIBA) 50 units/kg IV OR 4 factor PCC 50 units/kg IV Idarucizumab 5 g IV (in two 2.5 g/50 mL vials) consider hemodialysis or idarucizumab redosing for refractory bleeding after initial administration if 1) dabigatran was taken with 3-5 half lives and NO evidence of renal insufficiency or 2) dabigatran was taken beyond 3-5 half lives WITH renal insufficiency For other DTIs: Activated PCC (FEIBA) 50 units/kg IV OR 4 factor PCC 50 units/kg IV Unfractionated heparin: Protamine 1 mg IV for every 100 units of heparin administered in the previous 2–3 h (up to 50 mg in a single dose) LMWH Enoxaparin: Dosed within 8 h: Protamine 1 mg IV per 1 mg enoxaparin (up to 50 mg in a single dose) Dosed within 8–12 h: Protamine 0.5 mg IV per 1 mg enoxaparin (up to 50 mg in a single dose) Minimal utility in reversal >12 h from dosing Dalteparin, Nadroparin and Tinzaparin: Dosed within 3–5 half-lives of LMWH: Protamine 1 mg IV per 100 anti-Xa units of LMWH (up to 50 mg in a single dose) OR rFVIIa 90 mcg/kg IV if protamine is contraindicated Danaparoid: rFVIIa 90 mcg/kg IV Pentasaccharides: Activated PCC (FEIBA) 20 units/kg IV or rFVIIa 90 mcg/kg IV Thrombolytic agents (plasminogen activators): Cryoprecipitate 10 units IV OR antifibrinolytics (tranexamic acid 10–15 mg/kg IV over 20 min or e-aminocaproic acid 4–5 g IV) if cryoprecipitate is contraindicated Antiplatelet agents: DDAVP 0.4 mcg/kg x 1, if neurosurgical intervention, transfuse one apheresis unit

View Details

I am joined by Tony Mazzeo MD Chairman of Emergency Medicine at Mercy Catholic Medical Center and Vice Chairman of Mercy Operations for Department of EM at Drexel University College of Medicine. In this podcast we talk about getting efficient in the ED: Hot Stove Tips 1) empty the beds 2) Start with the dispo in mind (leave the room with a plan) and identify blockers 3) measure and track your throughput 4) anticipate problems 5)process in parallel and not serially

Hope you enjoy it and let me know if you agree!!!

View Details

What's ahead for pregnancy labeling categories - say goodbye to ABCDX! Useful links http://www.cdc.gov/pregnancy/meds/treatingfortwo/data.html http://www.nejm.org/doi/pdf/10.1056/NEJMp1316042

View Details

My heuristic to try manage this difficult clinical challenge!

View Details

First Pod Cast - describing the use of Hand Held Metal Detectors for pediatric swallowed coins